Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 4 | |
Outperform | 11 | |
Hold | 2 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 16 analysts offering 12 month price targets for Intra-Cellular Therapies Inc have a median target of 100.00, with a high estimate of 135.00 and a low estimate of 76.58. The median estimate represents a 16.70% increase from the last price of 85.69.
High | 57.5% | 135.00 |
Med | 16.7% | 100.00 |
Low | -10.6% | 76.58 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 20, 2025.
Average growth rate | -7.40% |
Average growth rate | +9.93% |
More ▼
Revenue history & estimates in USD
Average growth rate | +8.61% |
Average growth rate | +9,618.31% |
More ▼